Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Constitutive IL7 (C7R) Modified EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

NCT04664179 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT04664179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Constitutive IL7 (C7R) Modified EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Recruiting
Start date
October 31, 2022
Completion date
November 30, 2042
Enrollment
52 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ebv related non-hodgkin's lymphoma, ebv-related hodgkin lymphoma, ebv-related lymphoproliferative disorder